• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Examine the Medical Nanotechnology Markets

Posted on: Thursday, 9 October 2008, 12:00 CDT

Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.

Medical Nanotechnology Markets

http://www.reportlinker.com/p096369/Medical-Nanotechnology-Markets.html

Nanotechnology has reached critical mass. Nowhere is this more evident than in medicine. Rising medical costs, demands for less-invasive procedures and pressures for immediate feedback of medical conditions, all point to nanotechnology as offering a new approach in healthcare. According to U.S. National Science Foundation estimates, by 2015 the annual global market for nano-related goods and services will top $1 trillion, thus making it one of the fastest-growing industries in history. Assuming that these figures prove to be accurate, nanotechnology will emerge as a larger economic force than the combined telecommunications and information technology industries at the beginning of the technology boom of the late 1990s.

This TriMark Publications report covers the specific segments of the medical nanotechnology markets, with particular emphasis on those segments where this emerging technology is or shows the potential to be most impactful.

Nanotechnology, a field of science and technology that aims to control matter at the atomic, molecular and macromolecular level, potentially has far-reaching and paradigm-shifting implications for biology, drug discovery and medical technologies. The discipline has already yielded healthcare discoveries that have been used for drug delivery and diagnostic purposes. In this study, we describe various nanotechnologies under development for biological and medical purposes and assess their potential.

Moreover, this analysis is arranged to provide an overview of the regulatory issues faced by the medical nanotechnology industry and focuses on how specific segments within the industry are poised for high future growth.

 1 Overview 1.1 Statement of Report 1.2 About This Report 1.3 Scope of the Report 1.4 Methodology 1.5 Executive Summary 2 Medical Products (Drugs, Devices and Nutraceuticals) Nanotechnology  Markets 2.1 Background 2.2 Market Calculations 2.3 Market Demands 2.4 Market Overview  2.4.1 The Role of Nanotechnologies in Medicine 2.4.2 Nanotechnology Sector Challenges 2.4.3 Nanotechnology Sector Drivers 2.4.4 Nanotechnology Sector Restraints 2.5 Nanotechnology Medical Product Market Segments  2.5.1 Overview 2.5.2 World Markets 2.5.3 U.S. Market 2.5.4 European Market 2.5.5 Japanese Market 2.5.6 Asian Market 2.5.7 Middle East 2.5.8 ROW 3 Medical and Life Science Nanotechnology Markets 3.1 Nano-Particles 3.2 Market for Nano-Particles in Life Sciences and Medicine  3.2.1 Key Players 3.2.2 Application Manufacturers 3.3 Dendrimers  3.3.1 PAMAM Dendrimers 3.3.2 Market for Nanocapsules in Life Sciences and Healthcare 3.3.3 Key Players 3.4 Market for Nanoporous and Nanostructured Materials in Life Sciences  and Healthcare  3.4.1 Key Players 3.4.2 Nanofiltration  3.5.1 Sector Overview 3.5.2 Market for Quantum Dots in Life Sciences and Medicine 3.5.3 Commercial Applications for Quantum Dots 3.5.4 Key Players 3.5.5 Nanomaterials Suppliers 3.5.6 Application Manufacturers 3.6 Nanocoatings 3.7 Nanocomposites 3.8 Nanoarrays  3.8.1 Bead NanoArrays: A High-Sensitivity Detection System 3.9 Fullerenes  3.9.1 Key Applications and Market Opportunities 3.9.2 Medical Market Uses for Carbon Nanotubes 3.9.3 Key Players, Including Application Manufacturers, End Users and  Nanomaterials Suppliers 3.10 Liposome-like Nano-Particles  3.10.1 Nanostructured Lipid Carriers 3.10.2 DauxoXome(R) Liposomal Formulation 3.11 Nanosensors  3.11.1 Microcantilever Sensors and Photonic Sensors 3.11.2 Field-Effect Nanoplate Devices 3.11.3 Electrochemical-Transducing Electrode Systems 4 Technology Issues 4.1 Nanotechnology in Drug Delivery and Development  4.1.1 Drug Delivery Using Nanotechnology 4.1.2 Design of Nanotechnology-Based Drug Delivery Systems 4.1.3 Using Magnetic Nano-Particles in Targeted Drug Delivery 4.1.4 Cancer Drug Delivery 4.1.5 Nano-Particle-Mediated Delivery of siRNA 4.1.6 Targeting Angiogenesis with Nano-Particles 4.1.7 Nanosystems and Inflammation 4.1.8 The Chiral Drug Development Process 4.1.9 Reasons Why the Drug Delivery Market is Rapidly Expanding 4.2 Categories of Medical Nanotechnology Products  4.2.1 Surgical Steel Devices 4.2.2 Contrast-Enhancing Agents for MRI (Magnetic Resonance Imaging) 4.2.3 Wound Dressings / Anti-Microbial Textiles 4.2.4 Nanocoated Surgical Blades 4.2.5 Suture Needles and Microneedles 4.2.6 Catheters for Minimally-Invasive Surgery 4.2.7 Optical Nanosurgery 4.2.8 Nanocoated or Nanocontoured Implant Surfaces 4.3 Biosensors and Biodetection  4.3.1 Cantilever Arrays 4.3.2 Nanosensors 4.3.3 Optical Sensors 4.3.4 Nano-Particle Sensors and Detectors 4.3.5 In Vitro Diagnostics 4.3.6 Imaging, In Vivo Diagnosis and Theranostics 4.4 Vaccines-Virus-Like Particles (VLPs) 4.5 Transdermal Drug Delivery 4.6 Phage Microarrays 4.7 Neuroscience 4.8 Nanotechnology Materials for Medical Products  4.8.1 Dental Materials 4.8.2 Bone Replacement 4.8.3 Contact Lenses 4.9 New Drug Development 4.10 Future Directions  4.10.1 Sources of Nano Development 4.10.2 Commercialization 4.10.3 Current/Pending Clinical Trials on New Products and Emerging  Technologies 4.10.4 Future Directions 4.11 Key Technology Findings for Medical Uses of Nanotechnology 5 Business Trends 5.1 Market Forces  5.1.1 Market Drivers 5.1.2 Market Restraints 5.1.3 Medical / Clinical Studies 5.1.4 Demographics 5.2 Market Prospects 5.3 Marketing and Distribution 5.4 Competitive Landscape 5.5 Business Developments 5.5.1 Drug Pedigrees 5.6 Acquisitions and Partnerships 5.7 Key Players 5.8 Patent Climate 5.9 Investment Climate  5.9.1 U.S. Government 5.9.2 Europe 5.10 Venture Capital Environment  5.10.1 Medical and Health Nanotech Venture Companies 5.10.2 Pharma and Biotech Nanotech Venture Companies 5.11 Business Strategies for Medical Nanotechnology 5.12 Nanotechnology Questions  5.12.1 What Are the Near-Term Business Opportunities in the Medical Nanotechnology Markets? 5.12.2 What Are the Business Models Currently Used by Companies in the  Medical Nanotechnology Markets? 5.12.3 How Will Manufacturers, Researchers, Physicians, Patients and  Payers Influence the Medical Nanotechnology Markets? 5.12.4 What Are the Drivers and Bottlenecks Influencing the Medical  Nanotechnology Markets? 5.12.5 What Are the Current and Emerging Technologies used in the Medical  Nanotechnology Markets? 5.12.6 Who Holds the Proprietary Rights to the Medical Nanotechnology  Markets, Especially in such a Multidisciplinary Environment? 5.12.7 What Are Current Applications of These Technologies? 5.12.8 What Regulatory Processes Must Medical Nanotechnology Undergo  in the U.S., Japan and Europe? 5.12.9 How Will New or Emerging Medical Nanotechnologies Change  Treatment and Payment Paradigms? 5.12.10 How Will Medical Nanotechnologies Reduce Adverse Clinical  Reactions and Decrease Total Patient Care Cost? 5.12.11 How Will Medical Nanotechnology Reduce Healthcare Expenditures? 5.12.12 How Will Medical Nanotechnology Decrease Patient Diagnostic   Testin Costs? 5.12.13 What is the Role of Nanotechnology in Drug Development? 5.12.14 Which Medical Nanotechnology Product Categories Are Driving Growth? 5.12.15 How Are Biomarkers Being Developed Using Nanotechnology? 5.12.16 What Companies Are Developing Nanotechnology Drug Delivery Systems? 5.12.17 How Are Nano-Optical Tagging Technologies Used in Animal Drug  Safety Assessment Studies? 5.12.18 What Nanotechnology Platforms Are Being Used in Point of Care  Diagnostic Testing? 6 Technology Assessment 6.1 Current Technologies for Nano  6.1.1 Nanodiagnostics 6.1.2 Competitive Analysis of Nano-Particle Assays 6.1.3 In Vivo Imaging 6.1.4 In Vitro Clinical Diagnostics 6.2 Future Technologies 6.3 Technology Accelerators, Roadblocks and Challenges  6.3.1 Technology Accelerators 6.3.2 Technology Roadblocks and Challenges 6.3.3 Public Awareness 6.4 Nanotechnology Product Trends and New Concepts for Medical Applications  6.4.1 Market Trends-Diagnostics 6.4.2 Market Trends-Therapies 6.4.3 Market Trends-Preventive and Other 6.4.4 Nanofibers in Medical Applications 6.4.5 Dental Applications 6.4.6 Optical Applications 6.5 Production Methods 7 Medical Nanotechnology Market Regulation and Reimbursement 7.1 Market Segments  7.1.1 Diagnostics 7.1.2 Therapies 7.1.3 Preventive 7.2 Customer Needs 7.3 Competitor Analysis 7.4 Pricing Pressures 7.5 U.S. Medicare and Other Government Agency Issues 7.6 Third-Party Reimbursement 7.7 Regulatory Trends  7.7.1 Regulatory Policy for Nanotechnology Drugs and Medical Devices 7.7.2 Current Good Manufacturing Practices (cGMPs) 7.7.3 Current Progress 7.7.4 Future Regulatory Trends 7.7.5 Key Issues 7.7.6 Labeling Requirements 7.8 Government Initiatives  7.8.1 NNI Research Centers 7.8.2 NNI Centers and Networks of Excellence 7.8.3 FDA's Nanotechnology Task Force 7.8.4 Dutch Government Nano Action Plan 7.8.5 Other Research Centers 7.9 Medical Regulatory and cGMPs Issues 7.10 New Technology Concerns 7.11 Use Environment  7.11.1 Cancer 7.11.2 Medical Review 7.12 Risk Assessment 7.12.1 Risk Management (ISO 14971:2007) 7.12.2 Toxicology Assessment 7.12.3 Safety Evaluation 7.13 Cautions for Medical Nanotechnology Platforms 7.13.1 ETUC Precautionary Principle Applied to Nanotechnologies 7.13.2 Possible Risks to Human Health from Nanotechnology Products 8 Corporate Profiles 8.1 Abbott Laboratories 8.2 Abraxis Biosciences  8.2.1 NDA Pipeline 8.3 Aduro BioTech 8.4 Advanced Magnetics (AMAG Pharmaceuticals) 8.5 Alnis BioSciences 8.6 APP Pharmaceuticals 8.7 Arrowhead Research Corporation 8.8 Baxter International8.9 Bristol-Myers Squibb 8.10 Caliper 8.11 Capsulution NanoScience AG 8.12 CytRx Corporation 8.13 Dendritech, Inc. 8.14 Dendritic Nanotechnologies, Inc. 8.15 Dow Chemical 8.16 DuPont 8.16.1 The Framework 8.17 Elan Drug Delivery (see also Bristol-Myers Squibb) 8.18 Evident Technologies 8.19 Evolved Nanomaterial Sciences (ENS) 8.20 Flamel Technologies 8.21 General Electric 8.22 GlaxoSmithKline 8.23 Honeywell International 8.24 Invitrogen 8.25 Nano-C 8.26 Nanocyl SA 8.27 Nanogen, Inc. 8.28 Nanolab Systems 8.29 NanoPass Technologies, Ltd. 8.30 Nanophase Technologies Corporation 8.31 Nanospectra Biosciences 8.32 Nanosphere, Inc. 8.33 Nanosys 8.34 New England Precision Grinding (NEPG) 8.35 Novartis 8.36 Novavax 8.37 Nucryst (Westaim) Pharmaceuticals 8.38 Orthovita 8.39 Phillips 8.40 pSivida Corporation 8.41 Quantum Dot Corporation 8.42 Roche 8.43 Sandvik Bioline 8.44 Starpharma Holdings, Limited 8.45 Sigma Aldrich 8.46 Wyeth Pharmaceuticals 9 Appendix: Nanotechnology References 10 Appendix: Glossary of Terms in Nanotechnology 10.1 Bionanotechnology  10.1.1 Nanopore Sequencing 10.1.2 Cantilevers with Functionalized Tips 10.1.3 Microneedles 10.1.4 Microchips for Drug Delivery 10.1.5 Nucleic Acid Lattices and Scaffolds 10.1.6 Nanofibers as Biomaterials 10.1.7 Carbon Nanotubes 10.2 Definition of Nano-Particles with Biological and Medical Applications  10.2.1 Superparamagnetic Iron Oxide Crystals 10.2.2 Quantum Dots 10.2.3 Dendrimers 10.2.4 Polymeric Micelles 10.2.5 Liposomes 10.2.6 Nanospheres 10.2.7 Aquasomes (Carbohydrate-Ceramic Nano-Particles) 10.2.8 Polyplexes/Lipopolyplexes 11 Appendix: NNI Centers and Networks of Excellence 11.1 National Science Foundation 11.2 Department of Energy 11.3 Department of Defense 11.4 National Aeronautics and Space Administration (NASA) 11.5 National Institute for Occupational Safety and Health 11.6 National Institute of Standards and Technology 11.7 National Institutes of Health LIST OF FIGURES Figure 2.1: End-User Markets for Nanotechnology, 2007 Figure 2.2: Nanometer Scale Figure 2.3: International Per Capita Healthcare Spending by Country, 2006 Figure 2.4: World Nanomedical Market Shares, 2007 Figure 2.5: Total Spending on Healthcare in the U.S., 1960 to 2007 Figure 3.1: Nanotechnology Applications Figure 3.2: Carbon Nanotubes Figure 4.1: Depiction of nab Technology Figure 7.1: FDA Product Validation Chart Figure 7.2: FDA Product Lifecycle Model Figure 8.1: Sigma Aldrich Sales Distribution LIST OF TABLES Table 2.1: Global Market for Nanotechnology Products, 2005 to 2013 Table 2.2: Nanotechnology Materials for Consumer Products, 2005 to 2013 Table 2.3: Nanotechnology Markets Worldwide by Industry, 2002 to 2015 Table 2.4: Nanotechnology Development Worldwide by Region, 2002 to 2015 Table 2.5: Currently-Growing Nanofabrication Techniques Table 2.6: Global Nanomedicine Market, 2004 to 2013 Table 2.7: Nanomedicine Market Revenues by Product Segment, 2007 Table 2.8: Global Nanomedicine Market by Geographic Segment, 2004 to 2013 Table 2.9: U.S. Nanomedicine Market, 2004 to 2013 Table 2.10: European Nanomedicine Market, 2004 to 2013 Table 2.11: Japanese Nanomedicine Market, 2004 to 2013 Table 2.12: Japanese Nanotechnology Product Market Forecast Table 2.13: Government Funding for Nanotechnology Research and  Development, 1997 to 2008 Table 2.14: Global Nanotechnology R&D Spending, 1997 to 2013 Table 2.15: Global Growth in Nanotechnology R&D, 1997 to 2013 Table 3.1: Global Market for Nanotechnology Applications in the  Life Sciences, 2005 to 2012 Table 3.2: Market for Nano-Particles in Life Sciences and Medicine,  2004 to 2012 Table 3.2: Market for Nanostructured Materials in Life Sciences and  Medicine, 2004 to 2012 Table 3.4: Market for Nanodevices in Life Sciences and Medicine,  2004 to 2012 Table 3.5: Commercial Applications of Quantum Dots Table 3.6: Market for Nanocomposites in Life Sciences and Medicine,  2004 to 2012 Table 3.7: Liposomal Formulations Used in Nanotechnology Table 3.8: Types of Nanoparticulate Drug Delivery Systems Table 4.1: FDA-Approved Drugs Developed with Nanotechnology-Based  Formulations Table 4.2: Key Effectors of Drug Delivery Using Nanomaterials Table 4.3: Nanoscale Applications for Drug Delivery in Pharmaceutical  Drug Development Table 4.4: Drug Delivery Nanotechnology Market Drivers Ranked in Order  of Impact Table 4.5: Drug Delivery Nanotechnology Market Restraints Ranked in  Order of Impact Table 4.6: Anti-Cancer Drugs Formulated Using Nanomaterials Table 4.7: Nanomaterials for in vitro RNAi Delivery Table 4.8: Use of Peptide-Based Nanotubes for Biological Active Targets Table 4.9: Lab-on-Chip and Microfluidic Chip Technology Innovations Table 4.10: Diagnostic Nanotechnology Market Drivers Ranked in Order  of Impact Table 4.11: Diagnostic Nanotechnology Market Restraints Ranked in Order  of Impact Table 4.12: FDA-Approved In Vivo Imaging Materials Developed with  Nanotechnology-Based Formulations Table 4.13: Application Areas for Phage Nanotechnology Platforms Table 4.14: Application Areas for Neuroscience Nanotechnology Platforms Table 4.15: Nanotechnology Application Areas for Medical Nanomaterials Table 4.16: FDA-Approved Dental Biomaterials Developed with  Nanotechnology-Based Formulations Table 4.17: Drug Discovery Nanotechnology Market Drivers Ranked in Order of  Impact Table 4.18: Drug Discovery Nanotechnology Market Restraints Ranked in  Order of Impact Table 4.19: Examples of Proposed U.S. NNI Interagency Collaborative  Activities Table 5.1: Medical Nanotechnology Market Drivers-Global, 2008 to 2016 Table 5.2: Medical Nanotechnology Market Restraints-Global, 2008 to 2016 Table 5.3: U.S. Nanotechnology Patents Issued per Year, 1996 to 2006 Table 5.4: Sources of Nanotechnology Funds Table 5.5: National Government Funding Leaders for Nanotechnology, 2007 Table 5.6: Total Investments in Venture-Backed Nanotechnology Companies,  1997 to 2008 Table 5.7: Leading Nanotechnology Start-Up Companies Table 6.1: Summary of Key Advantages for Nanotechnology Table 6.2: Nanotechnology Platforms Used for Diagnostics and Imaging Table 6.3: FDA-Approved In Vitro Diagnostics Developed with  Nanotechnology-Based Formulations Table 6.4: Applications of Veridex Nanotechnology Platform for  Diagnostic Assays Table 6.5: Characteristics of Gold Nano-Particle Technology for Diagnostic  Testing Table 6.6: Overview of Future Nanomedical Technology Development Table 6.7: Recent Developments in Nanotechnology for Drug Delivery and Drug  Discovery Table 6.8: Recent Developments in Nanomaterials and Nanotechnology-Based  Devices Table 6.9: Recent Nanotechnology Applications in Diagnostics Table 6.10: Future Nanomedical Technology Platforms Table 6.11: Additional Global Market Trends Table 8.1: AMAG Nanotechnology Products and Candidates 

To order this report:

Medical Nanotechnology Markets

http://www.reportlinker.com/p096369/Medical-Nanotechnology-Markets.html

More market research reports here!

 Contacts: Reportlinker.com Nicolas US: (805) 652-2626 or Intl: +1-805-652-2626 Email: nbo@reportlinker.com

SOURCE: Reportlinker.com

Source: MARKET WIRE

More News in this Category